Literature DB >> 2724422

Thymic atrophy characteristic in transgenic mice that harbor pX genes of human T-cell leukemia virus type I.

Y Furuta1, S Aizawa, Y Suda, Y Ikawa, H Kishimoto, Y Asano, T Tada, A Hikikoshi, M Yoshida, M Seiki.   

Abstract

The human T-cell leukemia viruses (HTLV) are associated with T-cell malignancies in humans. The malignant transformation occurs after a long latency in some carriers, and its mechanism appears to be distinct from that of other classes of retroviruses which induce transformation through viral or cellular oncogenes. A widely postulated explanation is that the products of novel pX genes transactivate endogenous cellular genes which lead to tumor development in T cells. To directly examine the pathological effects of pX genes in vivo, we produced transgenic mice harboring the HTLV type I pX genes under several regulatory units: HTLV type I long terminal repeat, immunoglobulin enhancer-simian virus 40 promoter, and mouse mammary tumor virus long terminal repeat. Atrophy of the thymus was characteristic in these mice no matter which regulatory unit directed the expression of the genes.

Entities:  

Mesh:

Year:  1989        PMID: 2724422      PMCID: PMC250880     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.

Authors:  M Fujii; P Sassone-Corsi; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  Active ras and myc oncogenes can be compatible, but Sv40 large T antigen is specifically suppressed with normal differentiation of mouse embryonic stem cells.

Authors:  Y Suda; S Hirai; M Suzuki; Y Ikawa; S Aizawa
Journal:  Exp Cell Res       Date:  1988-09       Impact factor: 3.905

3.  Common site of integration of HTLV in cells of three patients with mature T-cell leukaemia-lymphoma: a retraction.

Authors:  B Hahn; V Manzari; S Colombini; G Franchini; R C Gallo; F Wong-Staal
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

4.  Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I.

Authors:  S L Cross; M B Feinberg; J B Wolf; N J Holbrook; F Wong-Staal; W J Leonard
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

5.  Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.

Authors:  M Maruyama; H Shibuya; H Harada; M Hatakeyama; M Seiki; T Fujita; J Inoue; M Yoshida; T Taniguchi
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

6.  Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development.

Authors:  A Leder; P K Pattengale; A Kuo; T A Stewart; P Leder
Journal:  Cell       Date:  1986-05-23       Impact factor: 41.582

7.  The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice.

Authors:  M Nerenberg; S H Hinrichs; R K Reynolds; G Khoury; G Jay
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

8.  A transgenic mouse model for human neurofibromatosis.

Authors:  S H Hinrichs; M Nerenberg; R K Reynolds; G Khoury; G Jay
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

9.  Bovine leukemia virus trans-activator p38tax activates heterologous promoters with a common sequence known as a cAMP-responsive element or the binding site of a cellular transcription factor ATF.

Authors:  I Katoh; Y Yoshinaka; Y Ikawa
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

10.  Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.

Authors:  Y Suda; S Aizawa; S Hirai; T Inoue; Y Furuta; M Suzuki; S Hirohashi; Y Ikawa
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  10 in total

1.  Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.

Authors:  B Zimmerman; S Niewiesk; M D Lairmore
Journal:  Vet Pathol       Date:  2010-05-04       Impact factor: 2.221

2.  Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo.

Authors:  G Feuer; J K Fraser; J A Zack; F Lee; R Feuer; I S Chen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

3.  Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.

Authors:  R Grassmann; S Berchtold; I Radant; M Alt; B Fleckenstein; J G Sodroski; W A Haseltine; U Ramstedt
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Distinct regions in human T-cell lymphotropic virus type I tax mediate interactions with activator protein CREB and basal transcription factors.

Authors:  N Adya; C Z Giam
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

5.  Augmentation of c-fos and c-jun expression in transgenic mice carrying the human T-cell leukemia virus type-I tax gene.

Authors:  Y Iwakura; M Tosu; E Yoshida; S Saijo; J Nakayama-Yamada; K Itagaki; M Asano; H Siomi; M Hatanaka; T Takeda
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

6.  Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I.

Authors:  W J Grossman; J T Kimata; F H Wong; M Zutter; T J Ley; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

7.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

Review 8.  Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.

Authors:  Daniel A Rauch; Lee Ratner
Journal:  Viruses       Date:  2011-06-21       Impact factor: 5.048

Review 9.  From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis.

Authors:  Eléonore Pérès; Eugénie Bagdassarian; Sébastien This; Julien Villaudy; Dominique Rigal; Louis Gazzolo; Madeleine Duc Dodon
Journal:  Viruses       Date:  2015-12-07       Impact factor: 5.048

10.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Mineki Saito; Toshio Matsuzaki; Yorifumi Satou; Jun-Ichirou Yasunaga; Kousuke Saito; Kimiyoshi Arimura; Masao Matsuoka; Yoshiro Ohara
Journal:  Retrovirology       Date:  2009-02-19       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.